mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.003 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.005 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.007 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.009 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.01 |